Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomedical Research Tax Credit: As Treasury Prepares First Awards, BIO Prepares Renewal Campaign

This article was originally published in The Pink Sheet Daily

Executive Summary

Citing survey that finds eligible firms bullish on employment impact of pending tax credits, biotech industry will seek extension and expansion of the $1 billion Therapeutic Discovery Project in 2011.

You may also be interested in...



Health Reform Delivers Cash to 3,000 Biotech/Healthcare Firms; Big Winner Is Immunomedics

Maximum single award was less than $250,000; the number of applications kept individual award levels down.

Health Reform Delivers Cash to 3,000 Biotech/Healthcare Firms; Big Winner Is Immunomedics

Maximum single award was less than $250,000; the number of applications kept individual award levels down.

Health Reform 101: Cashing In On Hidden Financial Aid Provisions

Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package

Topics

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel